Repare Therapeutics Gross Profit vs. Price To Book
| RPTX Stock | USD 2.81 0.16 5.39% |
Gross Profit | First Reported 2010-12-31 | Previous Quarter -80.1 M | Current Value -76.1 M | Quarterly Volatility 45.1 M |
For Repare Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Repare Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Repare Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Repare Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Repare Therapeutics over time as well as its relative position and ranking within its peers.
Repare |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repare Therapeutics. If investors know Repare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repare Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.99) | Revenue Per Share 1.572 | Quarterly Revenue Growth (0.96) | Return On Assets (0.23) | Return On Equity (0.41) |
The market value of Repare Therapeutics is measured differently than its book value, which is the value of Repare that is recorded on the company's balance sheet. Investors also form their own opinion of Repare Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Repare Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repare Therapeutics' market value can be influenced by many factors that don't directly affect Repare Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repare Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Repare Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repare Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Repare Therapeutics Price To Book vs. Gross Profit Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Repare Therapeutics's current stock value. Our valuation model uses many indicators to compare Repare Therapeutics value to that of its competitors to determine the firm's financial worth. Repare Therapeutics is rated third in gross profit category among its peers. It is rated fifth in price to book category among its peers . The ratio of Gross Profit to Price To Book for Repare Therapeutics is about 22,126,538 . Repare Therapeutics reported Gross Profit of (80.07 Million) in 2023. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Repare Therapeutics' earnings, one of the primary drivers of an investment's value.Repare Price To Book vs. Gross Profit
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Repare Therapeutics |
| = | 15.11 M |
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Repare Therapeutics |
| = | 0.68 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Repare Price To Book Comparison
Repare Therapeutics is currently under evaluation in price to book category among its peers.
Repare Therapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Repare Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Repare Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Repare Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Repare Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 28 K | 29.4 K | |
| Interest Income | 13.2 M | 13.8 M | |
| Operating Income | -116.2 M | -110.4 M | |
| Net Loss | -97.4 M | -92.6 M | |
| Income Before Tax | -103.2 M | -98 M | |
| Total Other Income Expense Net | 13 M | 13.7 M | |
| Net Loss | -26.1 M | -27.4 M | |
| Net Loss | -93.8 M | -89.1 M | |
| Income Tax Expense | -9.4 M | -8.9 M | |
| Net Interest Income | 13.2 M | 13.8 M | |
| Non Operating Income Net Other | 85.1 K | 89.4 K | |
| Change To Netincome | 26.4 M | 27.8 M | |
| Net Loss | (2.23) | (2.34) | |
| Income Quality | 1.36 | 1.42 | |
| Net Income Per E B T | 0.91 | 0.93 |
Repare Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Repare Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Repare Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Repare Therapeutics' important profitability drivers and their relationship over time.
Use Repare Therapeutics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Repare Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Repare Therapeutics will appreciate offsetting losses from the drop in the long position's value.Repare Therapeutics Pair Trading
Repare Therapeutics Pair Trading Analysis
The ability to find closely correlated positions to Repare Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Repare Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Repare Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Repare Therapeutics to buy it.
The correlation of Repare Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Repare Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Repare Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Repare Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Repare Therapeutics position
In addition to having Repare Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Non-Metallic and Industrial Metal Mining Thematic Idea Now
Non-Metallic and Industrial Metal Mining
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Non-Metallic and Industrial Metal Mining theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Non-Metallic and Industrial Metal Mining Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Repare Stock Analysis
When running Repare Therapeutics' price analysis, check to measure Repare Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repare Therapeutics is operating at the current time. Most of Repare Therapeutics' value examination focuses on studying past and present price action to predict the probability of Repare Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repare Therapeutics' price. Additionally, you may evaluate how the addition of Repare Therapeutics to your portfolios can decrease your overall portfolio volatility.